TABLE 1.
Dosing regimens for adalimumab*
| INDICATION | DOSING REGIMEN |
|---|---|
| Psoriatic arthritis; rheumatoid arthritis; ankylosing spondylitis | 40mg SC every other week |
| Psoriasis; uveitis (adult) | 80mg SC on Day 1, 40mg SC on Day 8, and then 40mg SC every other week |
| Crohn’s disease (adult); ulcerative colitis | 160mg SC on Day 1, 80mg SC on Day 15, 40mg SC on Day 29, and then 40mg SC every other week |
| Hidradenitis suppurativa | 160mg SC on Day 1, 80mg SC on Day 15, 40mg SC on Day 29, and then 40mg SC every week |
| *Dosing regimens listed are for FDA-approved adult indications for adalimumab. | |
| Adalimumab is also approved for juvenile idiopathic arthritis, pediatric uveitis, and pediatric Crohn’s disease with different dosing regimens than those described above. Source: AbbVie, Inc.29 | |
| SC: subcutaneously | |